[1]
|
Bansal, A.S., Bradley, A.S., Bishop, K.N., Kiani-Alikhan, S. and Ford, B. (2012) Chronic Fatigue Syndrome, the Immune System and Viral Infection. Brain, Behavior, and Immunity, 26, 24-31. https://doi.org/10.1016/j.bbi.2011.06.016
|
[2]
|
Carruthers, B.M., van de Sande, M.I., De Meirleir, K.L., Klimas, N.G., Broderick, G., Mitchell, T., Staines, D., Powles, A.C., Speight, N., Vallings, R., et al. (2011) Myalgic Encephalomyelitis: International Consensus Criteria. Journal of Internal Medicine, 270, 327-338. https://doi.org/10.1111/j.1365-2796.2011.02428.x
|
[3]
|
Johnston, S., Brenu, E.W., Staines, D. and Marshall-Gradisnik, S. (2013) The Prevalence of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Meta-Analysis. Clinical Epidemiology, 5, 105-110. https://doi.org/10.2147/CLEP.S39876
|
[4]
|
Aaron, L.A., Burke, M.M. and Buchwald, D. (2000) Overlapping Conditions among Patients with Chronic Fatigue Syndrome, Fibromyalgia, and Temporomandibular Disorder. Archives of Internal Medicine, 160, 221-227. https://doi.org/10.1001/archinte.160.2.221
|
[5]
|
Lembo, T.J. and Fink, R.N. (2002) Clinical Assessment of Irritable Bowel Syndrome. Journal of Clinical Gastroenterology, 35, S31-S36. https://doi.org/10.1097/00004836-200207001-00007
|
[6]
|
Barbara, G., De Giorgio, R., Stanghellini, V., Cremon, C., Salvioli, B. and Corinaldesi, R. (2004) New Pathophysiological Mechanisms in Irritable Bowel Syndrome. Alimentary Pharmacology & Therapeutics, 20, 1-9. https://doi.org/10.1111/j.1365-2036.2004.02036.x
|
[7]
|
Johnston, S.C., Staines, D.R. and Marshall-Gradisnik, S.M. (2016) Epidemiological Characteristics of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis in Australian Patients. Clinical Epidemiology, 8, 97-107. https://doi.org/10.2147/CLEP.S96797
|
[8]
|
Fremont, M., Coomans, D., Massart, S. and De Meirleir, K. (2013) High-Throughput 16S rRNA Gene Sequencing Reveals Alterations of Intestinal Microbiota in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. Anaerobe, 22, 50-56. https://doi.org/10.1016/j.anaerobe.2013.06.002
|
[9]
|
Frank, D.N., Robertson, C.E., Hamm, C.M., Kpadeh, Z., Zhang, T., Chen, H., Zhu, W., Sartor, R.B., Boedeker, E.C., Harpaz, N., et al. (2011) Disease Phenotype and Genotype Are Associated with Shifts in Intestinal-Associated Microbiota in Inflammatory Bowel Diseases. Inflammatory Bowel Diseases, 17, 179-184. https://doi.org/10.1002/ibd.21339
|
[10]
|
Giloteaux, L., Goodrich, J.K., Walters, W.A., Levine, S.M., Ley, R.E. and Hanson, M.R. (2016) Reduced Diversity and Altered Composition of the Gut Microbiome in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Microbiome, 4, 30. https://doi.org/10.1186/s40168-016-0171-4
|
[11]
|
ter Wolbeek, M., van Doornen, L.J., Kavelaars, A., van de Putte, E.M., Schedlowski, M. and Heijnen, C.J. (2007) Longitudinal Analysis of Pro- and Anti-Inflammatory Cytokine Production in Severely Fatigued Adolescents. Brain, Behavior, and Immunity, 21, 1063-1074. https://doi.org/10.1016/j.bbi.2007.04.007
|
[12]
|
Skowera, A., Cleare, A., Blair, D., Bevis, L., Wessely, S.C. and Peakman, M. (2004) High Levels of Type 2 Cytokine-Producing Cells in Chronic Fatigue Syndrome. Clinical & Experimental Immunology, 135, 294-302. https://doi.org/10.1111/j.1365-2249.2004.02354.x
|
[13]
|
Brenu, E.W., van Driel, M.L., Staines, D.R., Ashton, K.J., Ramos, S.B., Keane, J., Klimas, N.G. and Marshall-Gradisnik, S.M. (2011) Immunological Abnormalities as Potential Biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. Journal of Translational Medicine, 9, 81. https://doi.org/10.1186/1479-5876-9-81
|
[14]
|
Chia, J.K. and Chia, A.Y. (2008) Chronic Fatigue Syndrome Is Associated with Chronic Enterovirus Infection of the Stomach. Journal of Clinical Pathology, 61, 43-48. https://doi.org/10.1136/jcp.2007.050054
|
[15]
|
Kavelaars, A., Kuis, W., Knook, L., Sinnema, G. and Heijnen, C.J. (2000) Disturbed Neuroendocrine-Immune Interactions in Chronic Fatigue Syndrome. The Journal of Clinical Endocrinology & Metabolism, 85, 692-696.
|
[16]
|
Raison, C.L., Lin, J.M. and Reeves, W.C. (2009) Association of Peripheral Inflammatory Markers with Chronic Fatigue in a Population-Based Sample. Brain, Behavior, and Immunity, 23, 327-337. https://doi.org/10.1016/j.bbi.2008.11.005
|
[17]
|
Fletcher, M.A., Zeng, X.R., Barnes, Z., Levis, S. and Klimas, N.G. (2009) Plasma Cytokines in Women with Chronic Fatigue Syndrome. Journal of Translational Medicine, 7, 96. https://doi.org/10.1186/1479-5876-7-96
|
[18]
|
Broderick, G., Fuite, J., Kreitz, A., Vernon, S.D., Klimas, N. and Fletcher, M.A. (2010) A Formal Analysis of Cytokine Networks in Chronic Fatigue Syndrome. Brain, Behavior, and Immunity, 24, 1209-1217. https://doi.org/10.1016/j.bbi.2010.04.012
|
[19]
|
Clarke, G., Quigley, E.M., Cryan, J.F. and Dinan, T.G. (2009) Irritable Bowel Syndrome: Towards Biomarker Identification. Trends in Molecular Medicine, 15, 478-489. https://doi.org/10.1016/j.molmed.2009.08.001
|
[20]
|
Lee, K.J. and Tack, J. (2010) Altered Intestinal Microbiota in Irritable Bowel Syndrome. Neurogastroenterology & Motility, 22, 493-498. https://doi.org/10.1111/j.1365-2982.2010.01482.x
|
[21]
|
Maes, M., Mihaylova, I. and Leunis, J.C. (2007) Increased Serum IgM Antibodies Directed against Phosphatidyl Inositol (Pi) in Chronic Fatigue Syndrome (CFS) and Major Depression: Evidence That an IgM-Mediated Immune Response against Pi Is One Factor Underpinning the Comorbidity between both CFS and Depression. Neuro Endocrinology Letters, 28, 861-867.
|
[22]
|
Maes, M., Mihaylova, I. and Leunis, J.C. (2006) Chronic Fatigue Syndrome Is Accompanied by an IgM-Related Immune Response Directed against Neopitopes Formed by Oxidative or Nitrosative Damage to Lipids and Proteins. Neuro Endocrinology Letters, 27, 615-621.
|
[23]
|
Nilius, B. and Szallasi, A. (2014) Transient Receptor Potential Channels as Drug Targets: From the Science of Basic Research to the Art of Medicine. Pharmacological Reviews, 66, 676-814. https://doi.org/10.1124/pr.113.008268
|
[24]
|
Clapham, D.E. (2003) TRP Channels as Cellular Sensors. Nature, 426, 517-524. https://doi.org/10.1038/nature02196
|
[25]
|
Oberwinkler, J. and Philipp, S.E. (2007) TRPM3. Handbook of Experimental Pharmacology, 222, 427-459. https://doi.org/10.1007/978-3-642-54215-2_17
|
[26]
|
Marshall-Gradisnik, S., Huth, T., Chacko, A., Johnston, S., Smith, P. and Staines, D. (2016) Natural Killer Cells and Single Nucleotide Polymorphisms of Specific Ion Channels and Receptor Genes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. The Application of Clinical Genetics, 9, 39-47. https://doi.org/10.2147/TACG.S99405
|
[27]
|
Nguyen, T., Staines, D., Nilius, B., Smith, P. and Marshall-Gradisnik, S. (2016) Novel Identification and Characterisation of Transient Receptor Potential Melastatin 3 Ion Channels on Natural Killer Cells and B Lymphocytes: Effects on Cell Signalling in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients. Biological Research, 49, 27. https://doi.org/10.1186/s40659-016-0087-2
|
[28]
|
Nguyen, T., Johnston, S., Chacko, A., Gibson, D., Cepon, J., Smith, P., Staines, D. and Marshall-Gradisnik, S. (2016) Novel Characterisation of Mast Cell Phenotypes from Peripheral Blood Mononuclear Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients. Asian Pacific Journal of Allergy and Immunology, 35, 75-81.
|
[29]
|
Phelan, K.D., Shwe, U.T., Abramowitz, J., Wu, H., Rhee, S.W., Howell, M.D., Gottschall, P.E., Freichel, M., Flockerzi, V., Birnbaumer, L. and Zheng, F. (2013) Canonical Transient Receptor Channel 5 (TRPC5) and TRPC1/4 Contribute to Seizure and Excitotoxicity by Distinct Cellular Mechanisms. Molecular Pharmacology, 83, 429-438. https://doi.org/10.1124/mol.112.082271
|
[30]
|
Marshall-Gradisnik, S., Smith, P., Nilius, B. and Staines, D.R. (2015) Examination of Single Nucleotide Polymorphisms in Acetylcholine Receptors in Chronic Fatigue Syndrome Patients. Immunology and Immunogenetics Insights, 7, 7-20. https://doi.org/10.4137/III.S25105
|
[31]
|
Fukuda, K., Straus, S.E. Hickie, I., Sharpe, M.C., Dobbins, J.G. and Komaroff, A. (1994) The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study. International Chronic Fatigue Syndrome Study Group. Annals of Internal Medicine, 121, 953-959. https://doi.org/10.7326/0003-4819-121-12-199412150-00009
|
[32]
|
Hu, F.B. (2002) Dietary Pattern Analysis: A New Direction in Nutritional Epidemiology. Current Opinion in Lipidology, 13, 3-9. https://doi.org/10.1097/00041433-200202000-00002
|
[33]
|
Brenu, E.W., Ashton, K.J., Batovska, J., Staines, D.R. and Marshall-Gradisnik, S.M. (2014) High-Throughput Sequencing of Plasma microRNA in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. PLoS ONE, 9, e102783. https://doi.org/10.1371/journal.pone.0102783
|
[34]
|
Hardcastle, S.L., Brenu, E.W., Johnston, S., Nguyen, T., Huth, T., Ramos, S., Staines, D. and Marshall-Gradisnik, S. (2015) Longitudinal Analysis of Immune Abnormalities in Varying Severities of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients. Journal of Translational Medicine, 13, 299. https://doi.org/10.1186/s12967-015-0653-3
|
[35]
|
Fruhwald, J., Camacho Londono, J., Dembla, S., Mannebach, S., Lis, A., Drews, A., Wissenbach, U., Oberwinkler, J. and Philipp, S.E. (2012) Alternative Splicing of a Protein Domain Indispensable for Function of Transient Receptor Potential Melastatin 3 (TRPM3) Ion Channels. The Journal of Biological Chemistry, 287, 36663-36672. https://doi.org/10.1074/jbc.M112.396663
|
[36]
|
Komaroff, A.L. and Buchwald, D. (1991) Symptoms and Signs of Chronic Fatigue Syndrome. Reviews of Infectious Diseases, 13, S8-S11. https://doi.org/10.1093/clinids/13.Supplement_1.S8
|
[37]
|
Camus, F., Henzel, D., Janowski, M., Raguin, G., Leport, C. and Vildé, J. (1992) Unexplained Fever and Chronic Fatigue: Abnormal Circadian Temperature Pattern. The European Journal of Medicine, 1, 30-36.
|
[38]
|
Holzer, P. (2011) TRP Channels in the Digestive System. Current Pharmaceutical Biotechnology, 12, 24-34. https://doi.org/10.2174/138920111793937862
|
[39]
|
Holzer, P. (2007) Role of Visceral Afferent Neurons in Mucosal Inflammation and Defense. Current Opinion in Pharmacology, 7, 563-569. https://doi.org/10.1016/j.coph.2007.09.004
|
[40]
|
Light, A.R., Bateman, L., Jo, D., Hughen, R.W., Vanhaitsma, T.A., White, A.T. and Light, K.C. (2012) Gene Expression Alterations at Baseline and Following Moderate Exercise in Patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome. Journal of Internal Medicine, 271, 64-81. https://doi.org/10.1111/j.1365-2796.2011.02405.x
|
[41]
|
Akbar, A., Yiangou, Y., Facer, P., Brydon, W.G., Walters, J.R., Anand, P. and Ghosh, S. (2010) Expression of the TRPV1 Receptor Differs in Quiescent Inflammatory Bowel Disease with or without Abdominal Pain. Gut, 59, 767-774. https://doi.org/10.1136/gut.2009.194449
|
[42]
|
Cenac, N., Bautzova, T., Le Faouder, P., Veldhuis, N.A., Poole, D.P., Rolland, C., Bertrand, J., Liedtke, W., Dubourdeau, M., Bertrand-Michel, J., et al. (2015) Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients with Irritable Bowel Syndrome. Gastroenterology, 149, 433-444.e437. https://doi.org/10.1053/j.gastro.2015.04.011
|
[43]
|
Barbara, G., Stanghellini, V., De Giorgio, R., Cremon, C., Cottrell, G.S., Santini, D., Pasquinelli, G., Morselli-Labate, A.M., Grady, E.F., Bunnett, N.W., et al. (2004) Activated Mast Cells in Proximity to Colonic Nerves Correlate with Abdominal Pain in Irritable Bowel Syndrome. Gastroenterology, 126, 693-702. https://doi.org/10.1053/j.gastro.2003.11.055
|
[44]
|
D’Aldebert, E., Cenac, N., Rousset, P., Martin, L., Rolland, C., Chapman, K., Selves, J., Alric, L., Vinel, J. and Vergnolle, N. (2011) Transient Receptor Potential Vanilloid 4 Activated Inflammatory Signals by Intestinal Epithelial Cells and Colitis in Mice. Gastroenterology, 140, 275-285. https://doi.org/10.1053/j.gastro.2010.09.045
|
[45]
|
Ruggieri, M.R. and Braverman, A.S. (2013) Gastric Body Cholinergic Contractile Signal Transduction in M2 and M3 Receptor Knockout Mice. Journal of Receptor and Signal Transduction Research, 33, 249-254. https://doi.org/10.3109/10799893.2013.802803
|
[46]
|
Toth, B.I., Konrad, M., Ghosh, D., Mohr, F., Halaszovich, C.R., Leitner, M.G., Vriens, J., Oberwinkler, J. and Voets, T. (2015) Regulation of the Transient Receptor Potential Channel TRPM3 by Phosphoinositides. The Journal of General Physiology, 146, 51-63. https://doi.org/10.1085/jgp.201411339
|
[47]
|
Badheka, D., Borbiro, I. and Rohacs, T. (2015) Transient Receptor Potential Melastatin 3 Is a Phosphoinositide-Dependent Ion Channel. The Journal of General Physiology, 146, 65-77. https://doi.org/10.1085/jgp.201411336
|
[48]
|
Brenu, E.W., van Driel, M.L., Staines, D.R., Ashton, K.J., Hardcastle, S.L., Keane, J., Tajouri, L., Peterson, D., Ramos, S.B. and Marshall-Gradisnik, S.M. (2012) Longitudinal Investigation of Natural Killer Cells and Cytokines in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. Journal of Translational Medicine, 10, 88. https://doi.org/10.1186/1479-5876-10-88
|
[49]
|
Hardcastle, S.L., Brenu, E.W., Johnston, S., Nguyen, Huth, T., Wong, N., Ramos, S., Staines, D. and Marshall-Gradisnik, S. (2015) Characterisation of Cell Functions and Receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME). BMC Immunology, 16, 35. https://doi.org/10.1186/s12865-015-0101-4
|
[50]
|
Cooper, M.A., Fehniger, T.A. and Caligiuri, M.A. (2001) The Biology of Human Natural Killer-Cell Subsets. Trends in Immunology, 22, 633-640. https://doi.org/10.1016/S1471-4906(01)02060-9
|
[51]
|
Bashashati, M., Rezaei, N., Shafieyoun, A., McKernan, D.P., Chang, L., Ohman, L., Quigley, E.M., Schmulson, M., Sharkey, K.A. and Simren, M. (2014) Cytokine Imbalance in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. Neurogastroenterology & Motility, 26, 1036-1048. https://doi.org/10.1111/nmo.12358
|
[52]
|
Lakhan, S.E. and Kirchgessner, A. (2010) Gut Inflammation in Chronic Fatigue Syndrome. Nutrition & Metabolism, 7, 79. https://doi.org/10.1186/1743-7075-7-79
|